The Journal of the American Medical Association, JAMA today published world's first complete data of #Sinopharm Phase3 clinical trials: 14 days after 2nd shot, Efficacy: 100% against severe cases, 72.8-78.1% against #COVID19 , 99% neutralizing antibodies jamanetwork.com/journals/jama/…
@ChinaEmbSL This is a Good news for #China & #Srilanka 😁
@ChinaEmbSL So it takes 14 days to develop resistance? 😯. Will read the doc. Thanks.
@ChinaEmbSL @ChinaEmbSL thanks for making the evidence based actions, it's build confidence and acceptance among public. If the China can be more transparency on wider sectors . China is a great place to live and china will be acceptable by most nations. Thanks and all the best .
@ChinaEmbSL Can Rajitha and NMRA experts committee understand this?
@ChinaEmbSL At first place when China Gvt offered #Sinopharm #lka gvt RELUCTEND to Trust them, now world wide & WHO recognised, but its too Late on getting priority for our orders... @sajithpremadasa @HarshadeSilvaMP @EranWick island.lk/move-to-import…
@ChinaEmbSL Can't doubt this comparative study on vaccines